查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1889502

2025年全球哺乳动物细胞培养市场报告

Mammalian Cell Culture Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，哺乳动物细胞培养市场发展迅速，预计2024年至2025年将以11.2%的复合年增长率从43.7亿美元成长至48.6亿美元。过去几年的成长可归因于单株抗体产量增加、CHO和HEK293细胞株的广泛应用、疫苗需求的成长、学术和研究实验室实验活动的增加以及自体免疫和遗传性疾病盛行率的上升。

预计未来几年哺乳动物细胞培养市场将快速成长，到2029年市场规模将达到73.5亿美元，复合年增长率（CAGR）为10.9%。预测期内的成长要素包括：对扩充性哺乳动物细胞培养系统的日益重视、细胞疗法的广泛应用、临床试验投资的增加、生物製药生产能力的扩张以及对重组蛋白需求的增长。预测期内的主要趋势包括：3D细胞培养技术的进步、生物製程优化方面的创新、细胞株开发的进展、自动化和高通量筛检技术的进步以及污染控制和品质保证方面的创新。

未来几年，对个人化医疗日益增长的需求预计将推动哺乳动物细胞培养市场的成长。个人化医疗是指根据患者的遗传、环境和生活方式因素来客製化医疗方案，以提供更有效、更精准的治疗。对个人化医疗需求的增长源于透过根据个体的遗传和生物学特征量身定制治疗方法来改善治疗效果的能力。哺乳动物细胞培养在个人化医疗中发挥关键作用，它提供了一个可控的环境，用于研究患者的独特细胞，从而开发个人化治疗方法并测试药物反应。例如，根据美国非营利组织个人化医疗联盟（Personalized Medicine Coalition）2024年2月发布的消息，美国食品药物管理局（FDA）在2023年核准了16种用于治疗罕见疾病患者的新型个人化疗法，较2022年的6种显着增加。因此，对个人化医疗日益增长的需求正在推动哺乳动物细胞培养市场的成长。

哺乳动物细胞培养市场的主要企业正致力于培养基的创新，例如双组分培养基，以提高蛋白质产量、增强细胞活力并简化可扩展的生物製程流程，从而应用于治疗领域。双组分培养基系统是一种细胞培养方法，它使用两种不同的培养基成分——一种支持细胞的正常生长，另一种促进蛋白质表现——以提高整体生产效率。例如，总部位于瑞士的合约研发生产机构 (CDMO) Lonza 集团于 2023 年 7 月推出了 TheraPRO CHO 培养基系统。这款化学成分明确、不含动物源成分的培养基系统专为 GS-CHO 哺乳动物细胞株设计。该系统旨在透过提高细胞活力和蛋白质产量来提高治疗性蛋白质和单株抗体的生产效率。其可扩展的设计支持从细胞株开发到大规模生产的各个生物製程生产阶段。 Lonza 希望透过该产品帮助生物製药生产商简化工作流程、提高产品品质并缩短产品上市时间。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税，以及新冠疫情及其復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球哺乳动物细胞培养市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 终端用户产业分析
  • 全球哺乳动物细胞培养市场：成长率分析
  • 全球哺乳动物细胞培养市场表现：规模与成长，2019-2024年
  • 全球哺乳动物细胞培养市场预测：规模与成长，2024-2029年，2034年预测
  • 全球哺乳动物细胞培养市场：潜在市场规模（TAM）

第六章 市场细分

  • 全球哺乳动物细胞培养市场：依产品、效能及预测划分，2019-2024年、2024-2029年预测、2034年预测
  • 培养基
  • 血清
  • 试剂
  • 装置
  • 全球哺乳动物细胞培养市场（依细胞株系、表现及预测划分，2019-2024年、2024-2029年预测、2034年预测）
  • 中国仓鼠卵巢细胞（CHO）
  • 韦斯特研究所-38 (WI-38)
  • 大鼠神经癌细胞株（C6）
  • 人类胚胎肾293细胞（HEK293）
  • 亨丽埃塔·拉克斯（HeLa）
  • 全球哺乳动物细胞培养市场：依应用、效能和预测划分，2019-2024年、2024-2029年预测、2034年预测
  • 生物製药生产
  • 疫苗生产
  • 毒性测试
  • 药物筛检与开发
  • 组织工程与再生医学
  • 全球哺乳动物细胞培养市场：依最终用途划分，实际值及预测值，2019-2024年、2024-2029年预测值、2034年预测值
  • 製药和生物技术公司
  • 医院和诊断检查室
  • 研究和学术机构
  • 合约研究组织（CRO）
  • 全球哺乳动物细胞培养市场：依培养基、类型、表现及预测细分，2019-2024年、2024-2029年预测、2034年预测
  • 无血清培养基
  • 化学成分明确的培养基
  • 传统媒体
  • 无蛋白培养基
  • 特殊培养基
  • 客製化媒体准备
  • 全球哺乳动物细胞培养市场：依血清、类型、表现及预测细分，2019-2024年、2024-2029年预测、2034年预测
  • 牛（FBS）
  • 新生牛血清
  • 成人牛血清
  • 供体马血清
  • 全球哺乳动物细胞培养市场：依试剂、类型、表现及预测细分，2019-2024年、2024-2029年预测、2034年预测
  • 生长因子和细胞激素
  • 细胞分散试剂
  • 补充剂和添加剂
  • 冷冻保护剂
  • 缓衝液和盐溶液
  • 抗生素和抗真菌药
  • 全球哺乳动物细胞培养市场：按设备、类型、性能和预测进行细分，2019-2024年、2024-2029年预测、2034年预测
  • 生物反应器和发酵罐
  • 培养容器
  • 过滤系统
  • 离心机
  • 细胞计数器和分析仪
  • 培养箱
  • 生物安全柜
  • 显微镜
  • 冷藏/低温储存设备

第七章 区域和国家分析

  • 全球哺乳动物细胞培养市场：区域表现与预测，2019-2024年、2024-2029年预测、2034年预测
  • 全球哺乳动物细胞培养市场：依国家、绩效及预测划分，2019-2024 年、2024-2029 年预测、2034 年预测

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第十八章：法国市场

第十九章：义大利市场

第二十章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第三十章：竞争格局与公司概况

  • 哺乳动物细胞培养市场：竞争格局
  • 哺乳动物细胞培养市场：公司概况
    • Novartis AG Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • GE Healthcare Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Becton Dickinson and Company
  • Lonza Group AG
  • Avantor Inc.
  • Agilent Technologies Inc.
  • Charles river laboratories
  • Sartorius AG
  • Samsung biologics
  • Wuxi biologics
  • Bio-Techne Corporation
  • Miltenyi Biotec
  • STEMCELL Technologies
  • Takara Bio Inc.
  • Goodwin biotechnology
  • HiMedia Laboratories Private Limited
  • Promocell GmbH

第32章 全球市场竞争基准化分析与仪錶板

第33章 重大併购

第34章 近期市场趋势

第35章：高潜力市场国家、细分市场与策略

  • 2029年哺乳动物细胞培养市场：提供新机会的国家
  • 2029年哺乳动物细胞培养市场：新兴细分市场机会
  • 2029年哺乳动物细胞培养市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章附录

简介目录
Product Code: r40050

Mammalian cell culture is the process of growing animal cells under controlled laboratory conditions outside their natural environment. It involves maintaining cells in a nutrient-rich medium that supplies essential growth factors, gases, and conditions such as temperature and pH. This technique is widely used in research, biotechnology, and medicine for studying cell biology, producing vaccines, and testing drugs. It enables scientists to simulate in vivo conditions and observe cellular behavior in a controlled setting.

The main products used in mammalian cell culture include media, sera, reagents, and equipment. Media refers to nutrient-rich formulations designed to support the growth, proliferation, and maintenance of mammalian cells under controlled laboratory conditions. Key cell lines include Chinese hamster ovary (CHO), Wistar Institute-38 (WI-38), rat glial tumor cell line (C6), human embryonic kidney 293 (HEK293), and Henrietta Lacks (HeLa). Major applications span biopharmaceutical production, vaccine production, toxicity testing, drug screening and development, and tissue engineering and regenerative medicine, with primary end users including pharmaceutical and biotechnology companies, hospitals and diagnostic laboratories, research and academic institutes, and contract research organizations (CROs).

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The mammalian cell culture market research report is one of a series of new reports from The Business Research Company that provides mammalian cell culture market statistics, including the mammalian cell culture industry global market size, regional shares, competitors with the mammalian cell culture market share, detailed mammalian cell culture market segments, market trends, and opportunities, and any further data you may need to thrive in the mammalian cell culture industry. This mammalian cell culture market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The mammalian cell culture market size has grown rapidly in recent years. It will grow from $4.37 billion in 2024 to $4.86 billion in 2025 at a compound annual growth rate (CAGR) of 11.2%. Growth during the historic period can be attributed to the increasing production of monoclonal antibodies, the rising use of CHO and HEK293 cell lines, growing demand for vaccines, expansion of academic and research laboratory activities, and the increasing prevalence of autoimmune and genetic disorders.

The mammalian cell culture market size is expected to see rapid growth in the next few years. It will grow to $7.35 billion in 2029 at a compound annual growth rate (CAGR) of 10.9%. Growth in the forecast period can be attributed to a stronger focus on scalable mammalian cell culture systems, greater adoption of cell-based therapies, rising investment in clinical trials, expansion of biopharmaceutical manufacturing capabilities, and increasing demand for recombinant proteins. Major trends expected in the forecast period include technological advancements in 3D cell culture, innovations in bioprocess optimization, progress in cell line development, advancements in automation and high-throughput screening, and innovations in contamination control and quality assurance.

The increasing demand for personalized medicine is expected to drive the growth of the mammalian cell culture market in the coming years. Personalized medicine tailors medical treatment based on a patient's genetic, environmental, and lifestyle factors to provide more effective and precise care. The rise in demand for personalized medicine is driven by its ability to improve treatment outcomes by customizing therapies to an individual's genetic and biological profile. Mammalian cell culture plays a key role in personalized medicine by providing a controlled environment to study patient-specific cells, enabling the development of tailored therapies and testing drug responses for more accurate and effective treatments. For instance, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that the FDA approved 16 new personalized treatments for patients with rare diseases in 2023, a significant increase from the six approved in 2022. As a result, the increasing demand for personalized medicine is fueling the growth of the mammalian cell culture market.

Leading companies in the mammalian cell culture market are focusing on innovation in cell culture media, such as two-part production systems, to improve protein yield, enhance cell viability, and streamline scalable bioprocess workflows for therapeutic applications. A two-part production system is a cell culture method that uses two distinct media components: one to support general cell growth and the other to boost protein expression, improving overall productivity. For example, in July 2023, Lonza Group Ltd., a Switzerland-based contract development and manufacturing organization (CDMO), launched the TheraPRO CHO Media System. This chemically defined, animal-component-free media system is designed specifically for GS-CHO mammalian cell lines. It aims to enhance the production of therapeutic proteins and monoclonal antibodies by improving cell viability and protein yields. Its scalable design supports all stages of bioprocess manufacturing, from cell line development to large-scale production. With this launch, Lonza seeks to streamline workflows, improve product quality, and accelerate time-to-market for biopharmaceutical manufacturers.

In December 2024, Merck KGaA, a Germany-based science and technology company, acquired HUB Organoids Holding B.V. for an undisclosed amount. This acquisition aims to advance Merck's next-generation biology portfolio by integrating HUB's organoid technology to accelerate drug discovery, expand 3D cell-culture capabilities, and provide human-relevant models for disease modeling and toxicity testing. HUB Organoids Holding B.V., based in the Netherlands, specializes in mammalian cell culture-based organoid models that replicate human organ structure and function for research and therapeutic applications.

Major companies operating in the mammalian cell culture market are Novartis AG, Thermo Fisher Scientific Inc., Merck KGaA, Danaher Corporation, GE Healthcare, Becton Dickinson and Company, Lonza Group AG, Avantor Inc., Agilent Technologies Inc., Charles river laboratories, Sartorius AG, Samsung biologics, Wuxi biologics, Bio-Techne Corporation, Miltenyi Biotec, STEMCELL Technologies, Takara Bio Inc., Goodwin biotechnology, HiMedia Laboratories Private Limited, Promocell GmbH, Eppendorf AG, Cell Culture Company LLC, Cell X Technologies.

North America was the largest region in the mammalian cell culture market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in mammalian cell culture report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the mammalian cell culture market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The mammalian cell culture market consists of sales of media, sera, reagents, equipment, bioreactors, culture plates, flasks, incubators, centrifuges, and microscopes. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Mammalian Cell Culture Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on mammalian cell culture market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for mammalian cell culture ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The mammalian cell culture market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Media; Sera; Reagents; Equipment
  • 2) By Cell Line: Chinese Hamster Ovary (CHO); Wistar Institute-38 (WI-38); Rat Glial Tumor Cell Line (C6); Human Embryonic Kidney 293 (HEK293); Henrietta Lacks (HeLa)
  • 3) By Application: Biopharmaceutical Production; Vaccine Production; Toxicity Testing; Drug Screening and Development; Tissue Engineering And Regenerative Medicine
  • 4) By End-Use: Pharmaceutical And Biotechnology Companies; Hospitals And Diagnostic Laboratories; Research And Academic Institutes; Contract Research Organizations (CROS)
  • Subsegments:
  • 1) By Media: Serum-free Media; Chemically Defined Media; Classical Media; Protein-free Media; Specialty Media; Custom Media Formulations
  • 2) By Sera: Fetal Bovine Serum (FBS); Newborn Calf Serum; Adult Bovine Serum; Donor Horse Serum
  • 3) By Reagents: Growth Factors And Cytokines; Cell Dissociation Reagents; Supplements And Additives; Cryoprotective Agents; Buffers And Salt Solutions; Antibiotics And Antimycotics
  • 4) By Equipment: Bioreactors And Fermenters; Culture Vessels; Filtration Systems; Centrifuges; Cell Counters And Analyzers; Incubators; Biosafety Cabinets; Microscopes; Refrigeration And Cryostorage Equipment
  • Companies Mentioned: Novartis AG; Thermo Fisher Scientific Inc.; Merck KGaA; Danaher Corporation; GE Healthcare; Becton Dickinson and Company; Lonza Group AG; Avantor Inc.; Agilent Technologies Inc.; Charles river laboratories; Sartorius AG; Samsung biologics; Wuxi biologics; Bio-Techne Corporation; Miltenyi Biotec; STEMCELL Technologies; Takara Bio Inc.; Goodwin biotechnology; HiMedia Laboratories Private Limited; Promocell GmbH; Eppendorf AG; Cell Culture Company LLC; Cell X Technologies.
  • Countries:

Table of Contents

1. Executive Summary

2. Mammalian Cell Culture Market Characteristics

3. Mammalian Cell Culture Market Trends And Strategies

4. Mammalian Cell Culture Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Mammalian Cell Culture Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Mammalian Cell Culture PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Mammalian Cell Culture Market Growth Rate Analysis
  • 5.4. Global Mammalian Cell Culture Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Mammalian Cell Culture Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Mammalian Cell Culture Total Addressable Market (TAM)

6. Mammalian Cell Culture Market Segmentation

  • 6.1. Global Mammalian Cell Culture Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Media
  • Sera
  • Reagents
  • Equipment
  • 6.2. Global Mammalian Cell Culture Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Chinese Hamster Ovary (CHO)
  • Wistar Institute-38 (WI-38)
  • Rat Glial Tumor Cell Line (C6)
  • Human Embryonic Kidney 293 (HEK293)
  • Henrietta Lacks (HeLa)
  • 6.3. Global Mammalian Cell Culture Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Biopharmaceutical Production
  • Vaccine Production
  • Toxicity Testing
  • Drug Screening and Development
  • Tissue Engineering And Regenerative Medicine
  • 6.4. Global Mammalian Cell Culture Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pharmaceutical And Biotechnology Companies
  • Hospitals And Diagnostic Laboratories
  • Research And Academic Institutes
  • Contract Research Organizations (CROS)
  • 6.5. Global Mammalian Cell Culture Market, Sub-Segmentation Of Media, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Serum-free Media
  • Chemically Defined Media
  • Classical Media
  • Protein-free Media
  • Specialty Media
  • Custom Media Formulations
  • 6.6. Global Mammalian Cell Culture Market, Sub-Segmentation Of Sera, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Fetal Bovine Serum (FBS)
  • Newborn Calf Serum
  • Adult Bovine Serum
  • Donor Horse Serum
  • 6.7. Global Mammalian Cell Culture Market, Sub-Segmentation Of Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Growth Factors And Cytokines
  • Cell Dissociation Reagents
  • Supplements And Additives
  • Cryoprotective Agents
  • Buffers And Salt Solutions
  • Antibiotics And Antimycotics
  • 6.8. Global Mammalian Cell Culture Market, Sub-Segmentation Of Equipment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bioreactors And Fermenters
  • Culture Vessels
  • Filtration Systems
  • Centrifuges
  • Cell Counters And Analyzers
  • Incubators
  • Biosafety Cabinets
  • Microscopes
  • Refrigeration And Cryostorage Equipment

7. Mammalian Cell Culture Market Regional And Country Analysis

  • 7.1. Global Mammalian Cell Culture Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Mammalian Cell Culture Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Mammalian Cell Culture Market

  • 8.1. Asia-Pacific Mammalian Cell Culture Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Mammalian Cell Culture Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Mammalian Cell Culture Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Mammalian Cell Culture Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Mammalian Cell Culture Market

  • 9.1. China Mammalian Cell Culture Market Overview
  • 9.2. China Mammalian Cell Culture Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Mammalian Cell Culture Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Mammalian Cell Culture Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Mammalian Cell Culture Market

  • 10.1. India Mammalian Cell Culture Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Mammalian Cell Culture Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Mammalian Cell Culture Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Mammalian Cell Culture Market

  • 11.1. Japan Mammalian Cell Culture Market Overview
  • 11.2. Japan Mammalian Cell Culture Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Mammalian Cell Culture Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Mammalian Cell Culture Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Mammalian Cell Culture Market

  • 12.1. Australia Mammalian Cell Culture Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Mammalian Cell Culture Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Mammalian Cell Culture Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Mammalian Cell Culture Market

  • 13.1. Indonesia Mammalian Cell Culture Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Mammalian Cell Culture Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Mammalian Cell Culture Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Mammalian Cell Culture Market

  • 14.1. South Korea Mammalian Cell Culture Market Overview
  • 14.2. South Korea Mammalian Cell Culture Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Mammalian Cell Culture Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Mammalian Cell Culture Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Mammalian Cell Culture Market

  • 15.1. Western Europe Mammalian Cell Culture Market Overview
  • 15.2. Western Europe Mammalian Cell Culture Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Mammalian Cell Culture Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Mammalian Cell Culture Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Mammalian Cell Culture Market

  • 16.1. UK Mammalian Cell Culture Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Mammalian Cell Culture Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Mammalian Cell Culture Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Mammalian Cell Culture Market

  • 17.1. Germany Mammalian Cell Culture Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Mammalian Cell Culture Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Mammalian Cell Culture Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Mammalian Cell Culture Market

  • 18.1. France Mammalian Cell Culture Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Mammalian Cell Culture Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Mammalian Cell Culture Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Mammalian Cell Culture Market

  • 19.1. Italy Mammalian Cell Culture Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Mammalian Cell Culture Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Mammalian Cell Culture Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Mammalian Cell Culture Market

  • 20.1. Spain Mammalian Cell Culture Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Mammalian Cell Culture Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Mammalian Cell Culture Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Mammalian Cell Culture Market

  • 21.1. Eastern Europe Mammalian Cell Culture Market Overview
  • 21.2. Eastern Europe Mammalian Cell Culture Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Mammalian Cell Culture Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Mammalian Cell Culture Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Mammalian Cell Culture Market

  • 22.1. Russia Mammalian Cell Culture Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Mammalian Cell Culture Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Mammalian Cell Culture Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Mammalian Cell Culture Market

  • 23.1. North America Mammalian Cell Culture Market Overview
  • 23.2. North America Mammalian Cell Culture Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Mammalian Cell Culture Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Mammalian Cell Culture Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Mammalian Cell Culture Market

  • 24.1. USA Mammalian Cell Culture Market Overview
  • 24.2. USA Mammalian Cell Culture Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Mammalian Cell Culture Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Mammalian Cell Culture Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Mammalian Cell Culture Market

  • 25.1. Canada Mammalian Cell Culture Market Overview
  • 25.2. Canada Mammalian Cell Culture Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Mammalian Cell Culture Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Mammalian Cell Culture Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Mammalian Cell Culture Market

  • 26.1. South America Mammalian Cell Culture Market Overview
  • 26.2. South America Mammalian Cell Culture Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Mammalian Cell Culture Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Mammalian Cell Culture Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Mammalian Cell Culture Market

  • 27.1. Brazil Mammalian Cell Culture Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Mammalian Cell Culture Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Mammalian Cell Culture Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Mammalian Cell Culture Market

  • 28.1. Middle East Mammalian Cell Culture Market Overview
  • 28.2. Middle East Mammalian Cell Culture Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Mammalian Cell Culture Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Mammalian Cell Culture Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Mammalian Cell Culture Market

  • 29.1. Africa Mammalian Cell Culture Market Overview
  • 29.2. Africa Mammalian Cell Culture Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Mammalian Cell Culture Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Mammalian Cell Culture Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Mammalian Cell Culture Market Competitive Landscape And Company Profiles

  • 30.1. Mammalian Cell Culture Market Competitive Landscape
  • 30.2. Mammalian Cell Culture Market Company Profiles
    • 30.2.1. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. GE Healthcare Overview, Products and Services, Strategy and Financial Analysis

31. Mammalian Cell Culture Market Other Major And Innovative Companies

  • 31.1. Becton Dickinson and Company
  • 31.2. Lonza Group AG
  • 31.3. Avantor Inc.
  • 31.4. Agilent Technologies Inc.
  • 31.5. Charles river laboratories
  • 31.6. Sartorius AG
  • 31.7. Samsung biologics
  • 31.8. Wuxi biologics
  • 31.9. Bio-Techne Corporation
  • 31.10. Miltenyi Biotec
  • 31.11. STEMCELL Technologies
  • 31.12. Takara Bio Inc.
  • 31.13. Goodwin biotechnology
  • 31.14. HiMedia Laboratories Private Limited
  • 31.15. Promocell GmbH

32. Global Mammalian Cell Culture Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Mammalian Cell Culture Market

34. Recent Developments In The Mammalian Cell Culture Market

35. Mammalian Cell Culture Market High Potential Countries, Segments and Strategies

  • 35.1 Mammalian Cell Culture Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Mammalian Cell Culture Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Mammalian Cell Culture Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer